References
Cameron HA, Ramsay LE. Ketanserin in essential hypertension: a double blind placebo controlled study. Postgraduate Medical Journal 61: 583–586, 1985
Kane J, Tooley M, Sibbald B, Gould SE. A comparative study of ketanserin and metoprolol in essential hypertension. Journal of Hypertension 4(Suppl. 1): S63–S65, 1986
Kaplan NM. Clinical hypertension, 4th ed., Williams and Wilkins, 1986
Medical Research Council (MRC) Working party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 2: 539, 1981
Ram CVS, Gonzalez DG, Kaplan NM, Ralakis JM, Henderson JD, et al. Renal haemodynamic effects of ketanserin therapy in essential hypertension. Journal of Cardiovascular Pharmacology 10(Suppl. 3): S78–S80, 1987
Rosendorff C, Murray GD. Ketanserin versus metoprolol and hydrochlorothiazide in essential hypertension: only ketanserin’s hypotensive effect is age related. Journal of Hypertension 4(Suppl. 6): S109–S111, 1986
Schalekamp MADH, Woittiez AJJ, Wenting GJ, van den Meiraker AH, et al. Ketanserin: haemodynamic effects and mechanism of action. Journal of Hypertension 4(Suppl. 11): S7–S12, 1986
Symoens J. Clinical profile of a novel antihypertensive agent ketanserin. In Serotonin antagonist in hypertension, Update, Siebert Publications, Guildford, UK, 1986
Turner JF, Gould SE, Welburn PJ, Whitehead PA. The effect of antihypertensive treatment on the assessment of well-being in a general practice population. Journal of Hypertension 5(Suppl. 5): S529–S531, 1987
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Bayman, I.W., Gould, S.E., Turner, J.F. et al. Comparative Study of Ketanserin and Hydrochlorothiazide in Essential Hypertension. Drugs 36 (Suppl 1), 140–143 (1988). https://doi.org/10.2165/00003495-198800361-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800361-00028